For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Lipoxen Technologies Incorporated

Calculating rank

USPTO Granted Patents = 57

% Expired Patents = 24.6

EPO Patents = 15

Trademarks = 2

Forward Citations = 200

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Sanjay Jain (43 out of 44 patents)

Gregory Gregoriadis (37 out of 40 patents)

Peter Laing (36 out of 36 patents)

4. Ioannis Papaioannou (22 out of 22 patents)

5. Smita Thobhani (10 out of 10 patents)

6. Norbert Oskar Rumpf (8 out of 8 patents)

7. Dale Howard Hreczuk-Hirst (7 out of 8 patents)

8. Andrew David Bacon (6 out of 7 patents)

9. Wilson Romero Caparros-Wanderley (4 out of 28 patents)

10. Hanspeter Rottensteiner (2 out of 35 patents)

11. Peter Turecek (2 out of 120 patents)

12. Juergen Siekmann (2 out of 45 patents)

13. Stefan Haider (2 out of 13 patents)

14. Archana Dwivedi (2 out of 2 patents)

15. Srijit Nath (2 out of 2 patents)

Core Competencies:

Glycopolysialylation

Sialic Acid Derivatives

Polysialic Acid

Liposomal Vaccines

Protein Derivatisation

Endotoxin Reduction

Immunotherapy

N-terminal Derivatisation

Charged Polysaccharides

Erythropoietin

Granulocyte Colony-Stimulating Factor

Cationic Liposomes

57 patents: Sort by Forward Citations

1. 10772968 - Glycopolysialylation of non-blood coagulation proteins (2020-09-15),

2. 10494449 - Fractionation of charged polysaccharide (2019-12-03),

3. 10406209 - Sialic acid derivatives for protein derivatisation and conjugation (2019-09-10),

4. 10406150 - Method for treatment of primary hormone resistant endometrial and breast cancers (2019-09-10),

5. 10301396 - Reduction of endotoxin in polysialic acids (2019-05-28),

6. 10300144 - N-terminal polysialylation (2019-05-28),

7. 10155046 - Activated sialic acid derivatives for protein derivatisation and conjugation (2018-12-18),

8. 10155045 - Activated sialic acid derivatives for protein derivatisation and conjugation (2018-12-18),

9. 9920137 - Polysialic acid derivatives (2018-03-20),

10. 9828443 - Fractionation of charged polysaccharide (2017-11-28),

11. 9795683 - Glycopolysialylation of non-blood coagulation proteins (2017-10-24),

12. 9790288 - Fractionation of charged polysaccharide (2017-10-17),

13. 9789163 - N-terminal derivatisation of proteins with polysaccharides (2017-10-17),

14. 9750692 - Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant (2017-09-05),

15. 9579393 - Derivatisation of erythropoietin (EPO) (2017-02-28),

Company Overview

Lipoxen Technologies Incorporated, based in London, specializes in the field of polysaccharide derivatisation, focusing on innovative approaches to drug delivery and immunotherapy. The company is known for its expertise in glycopolysialylation and the development of sialic acid derivatives, which play a crucial role in enhancing the efficacy of liposomal vaccines and protein derivatisation. Their research aims to improve therapeutic outcomes through advanced techniques such as endotoxin reduction and N-terminal derivatisation, positioning them at the forefront of biopharmaceutical innovation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

57 Patents

#73 in London

#310 in United Kingdom

#12,581 in the World

London, United Kingdom

Lipoxen Technologies Incorporated

Forward Citations = 200

23 inventors:

Sanjay Jain (43 out of 44 patents)

Gregory Gregoriadis (37 out of 40 patents)

Peter Laing (36 out of 36 patents)

4. Ioannis Papaioannou (22 out of 22 patents)

5. Smita Thobhani (10 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lipoxen Technologies Incorporated. Retrieved from https://idiyas.com/company/lipoxen-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…